Literature DB >> 12053427

Best practice in undertaking and reporting health technology assessments. Working group 4 report.

Marcial Velasco1, Matthias Perleth, Michael Drummond, Felix Gürtner, Torben Jørgensen, Albert Jovell, Jim Malone, Alric Rüther, Claudia Wild.   

Abstract

Mesh：

Year:  2002        PMID： 12053427     DOI： 10.1017/s0266462302000284

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN： 0266-4623            Impact factor:   2.188


× No keyword cloud information.
  25 in total

1.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

Review 2.  [When is expensive pharmacotherapy good value for the money?].

Authors:  A Riesberg; M Velasco-Garrido; S Weinbrenner; C A Gericke; R Busse
Journal:  Internist (Berl)       Date:  2004-10       Impact factor: 0.743

Review 3.  [Value-based medicine in ophthalmology].

Authors:  C Hirneiss; A S Neubauer; C Tribus; A Kampik
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

Review 4.  [Health technology assessment (HTA). Developments in healthcare and potential for radiology].

Authors:  E R Gizewski; M Forsting; G A Krombach; O Schöffski
Journal:  Radiologe       Date:  2014-06       Impact factor: 0.635

5.  Talkin' About a Resolution: Issues in the Push for Greater Transparency of Medicine Prices.

Authors:  Brendan Shaw; Jorge Mestre-Ferrandiz
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

Review 6.  Stated and Revealed Preferences for Funding New High-Cost Cancer Drugs: A Critical Review of the Evidence from Patients, the Public and Payers.

Authors:  Tatjana E MacLeod; Anthony H Harris; Ajay Mahal
Journal:  Patient       Date:  2016-06       Impact factor: 3.883

7.  Ethical analysis to improve decision-making on health technologies.

Authors:  Samuli I Saarni; Bjørn Hofmann; Kristian Lampe; Dagmar Lühmann; Marjukka Mäkelä; Marcial Velasco-Garrido; Ilona Autti-Rämö
Journal:  Bull World Health Organ       Date:  2008-08       Impact factor: 9.408

8.  Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria.

Authors:  Deodato Assanelli; Rosella Levaggi; François Carré; Sanjay Sharma; Asterios Deligiannis; Klaus Peter Mellwig; Mohamed Tahmi; Giovanni Vinetti; Paola Aliverti
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

9.  Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.

Authors:  Michèle Tony; Monika Wagner; Hanane Khoury; Donna Rindress; Tina Papastavros; Paul Oh; Mireille M Goetghebeur
Journal:  BMC Health Serv Res       Date:  2011-11-30       Impact factor: 2.655

Review 10.  Defining the "Health Benefit Basket" in nine European countries. Evidence from the European Union Health BASKET Project.

Authors:  J Schreyögg; T Stargardt; M Velasco-Garrido; R Busse
Journal:  Eur J Health Econ       Date:  2005-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.